Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Harris, Kristina ^a   Kassis, Amira ^b   Major, Geneviève ^b   Chou, Chieh J ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; HIPPURIC ACID; LEPTIN RECEPTOR; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PEPTIDOGLYCAN; PROTEIN FIAF; RNA 16S; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BODY WEIGHT; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIET RESTRICTION; ENERGY EXPENDITURE; FLAGELLUM; FOOD INTAKE; GENE SEQUENCE; GENOTYPE; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; INTESTINE FLORA; LIPID METABOLISM; METABOLIC DISORDER; METAGENOMICS; MORBID OBESITY; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 84866309777     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/879151     Document Type: Review

References (113)

1. World Health Organization, Obesity and Overweight. 2007
2. Suau A., Bonnet R., Sutren M., Godon J. J., Gibson G. R., Collins M. D., Doré J., Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Applied and Environmental Microbiology 1999 65 11 4799 4807 2-s2.0-0032755259
3. Savage D. C., Microbial ecology of the gastrointestinal tract. Annual Review of Microbiology 1977 31 107 133 2-s2.0-0017341656
4. Andersson A. F., Lindberg M., Jakobsson H., Bäckhed F., Nyrén P., Engstrand L., Lars.Engstrand@smi.ki.se Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008 3 7 10.1371/journal.pone. 0002836 e2836
5. Frank D. N., Pace N. R., Gastrointestinal microbiology enters the metagenomics era. Current Opinion in Gastroenterology 2008 24 1 4 10 2-s2.0-36549028432 10.1097/MOG.0b013e3282f2b0e8 (Pubitemid 350190890)
6. Eckburg P. B., Bik E. M., Bernstein C. N., Purdom E., Dethlefsen L., Sargent M., Gill S. R., Nelson K. E., Relman D. A., Diversity of the human intestinal microbial flora. Science 2005 308 5728 1635 1638 2-s2.0-20544444045 10.1126/science.1110591 (Pubitemid 40807514)
7. Ley R. E., Turnbaugh P. J., Klein S., Gordon J. I., Microbial ecology: human gut microbes associated with obesity. Nature 2006 444 7122 1022 1023 2-s2.0-33845901507 10.1038/4441022a (Pubitemid 46018512)
8. Hattori M., Taylor T. D., The human intestinal microbiome: a new frontier of human biology. DNA Research 2009 16 1 1 12 2-s2.0-65249119418 10.1093/dnares/dsn033
9. Miller T. L., Wolin M. J., Stability of Methanobrevibacter smithii populations in the microbial flora excreted from the human large bowel. Applied and Environmental Microbiology 1983 45 1 317 318 2-s2.0-0020628235 (Pubitemid 13110684)
10. Simon G. L., Gorbach S. L., Intestinal flora in health and disease. Gastroenterology 1984 86 1 174 193 2-s2.0-0021328175 (Pubitemid 14177335)
11. Frank D. N., Amand A. L. S., Feldman R. A., Boedeker E. C., Harpaz N., Pace N. R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13780 13785 2-s2.0-35348857386 10.1073/pnas.0706625104 (Pubitemid 350003397)
12. Goodman A. L., Kallstrom G., Faith J. J., Reyes A., Moore A., Dantas G., Gordon J. I., jgordon@wustl.edu Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proceedings of the National Academy of Sciences of the United States of America 2011 108 15 6252 6257 10.1073/pnas.1102938108
13. Bik E. M., Eckburg P. B., Gill S. R., Nelson K. E., Purdom E. A., Francois F., Perez-Perez G., Blaser M. J., Relman D. A., Molecular analysis of the bacterial microbiota in the human stomach. Proceedings of the National Academy of Sciences of the United States of America 2006 103 3 732 737 2-s2.0-31444449652 10.1073/pnas.0506655103 (Pubitemid 43153094)
14. Paster B. J., Boches S. K., Galvin J. L., Ericson R. E., Lau C. N., Levanos V. A., Sahasrabudhe A., Dewhirst F. E., Bacterial diversity in human subgingival plaque. Journal of Bacteriology 2001 183 12 3770 3783 2-s2.0-0034992657 10.1128/JB.183.12.3770-3783.2001 (Pubitemid 32510445)
15. Pei Z., Bini E. J., Yang L., Zhou M., Francois F., Blaser M. J., Bacterial biota in the human distal esophagus. Proceedings of the National Academy of Sciences of the United States of America 2004 101 12 4250 4255 2-s2.0-1642488364 10.1073/pnas.0306398101 (Pubitemid 38405915)
16. Ley R. E., Bäckhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I., Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 2005 102 31 11070 11075 2-s2.0-23344442120 10.1073/pnas.0504978102 (Pubitemid 41105994)
17. Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J. I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006 444 7122 1027 1031 2-s2.0-33845874101 10.1038/nature05414 (Pubitemid 46018515)
18. Duncan S. H., Lobley G. E., Holtrop G., Ince J., Johnstone A. M., Louis P., Flint H. J., Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity 2008 32 11 1720 1724 2-s2.0-56549122798 10.1038/ijo.2008.155
19. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N. A., Donus C., Hardt P. D., Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010 18 1 190 195 2-s2.0-73949137604 10.1038/oby.2009.167
20. Jumpertz R., jumpertzr@mail.nih.gov Le D. S., Turnbaugh P. J., Trinidad C., Bogardus C., Gordon J. I., Krakoff J., Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. American Journal of Clinical Nutrition 2011 94 1 58 65 10.3945/ajcn.110.010132
21. Santacruz A., Marcos A., Wärnberg J., Martí A., Martin-Matillas M., Campoy C., Moreno L. A., Veiga O., Redondo-Figuero C., Garagorri J. M., Azcona C., Delgado M., García-Fuentes M., Collado M. C., Sanz Y., yolsanz@iata.csic.es Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009 17 10 1906 1915 10.1038/oby.2009.112
22. Nadal I., Santacruz A., Marcos A., Warnberg J., Garagorri M., Moreno L. A., Martin-Matillas M., Campoy C., Martí A., Moleres A., Delgado M., Veiga O. L., García-Fuentes M., Redondo C. G., Sanz Y., Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. International Journal of Obesity 2009 33 7 758 767 2-s2.0-67650445962 10.1038/ijo.2008.260
23. Zhang H., DiBaise J. K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., Parameswaran P., Crowell M. D., Wing R., Rittmann B. E., Krajmalnik-Brown R., Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 2009 106 7 2365 2370 2-s2.0-60549086580 10.1073/pnas.0812600106
24. Furet J. P., Kong L. C., Tap J., Poitou C., Basdevant A., Bouillot J. L., Mariat D., Corthier G., Doré J., Henegar C., Rizkalla S., Clément K., Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010 59 12 3049 3057 2-s2.0-78650037263 10.2337/db10-0253
25. Li J. V., Ashrafian H., Bueter M., Kinross J., Sands C., Le Roux C. W., Bloom S. R., Darzi A., Athanasiou T., Marchesi J. R., marchesijr@cardiff.ac.uk Nicholson J. K., Holmes E., elaine.holmes@imperial.ac.uk Metabolic surgery profoundly influences gut microbialhost metabolic cross-talk. Gut 2011 60 9 1214 1223 10.1136/gut.2010.234708
26. Geurts L., Lazarevic V., Derrien M., Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Frontiers in Microbiology 2011 2, article 149
27. Turnbaugh P. J., Bäckhed F., Fulton L., Gordon J. I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host and Microbe 2008 3 4 213 223 2-s2.0-41849127118 10.1016/j.chom.2008.02.015 (Pubitemid 351494716)
28. Murphy E. F., Cotter P. D., Healy S., Marques T. M., O'Sullivan O., Fouhy F., Clarke S. F., O'Toole P. W., Quigley E. M., Stanton C., Ross P. R., O'Doherty R. M., Shanahan F., Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010 59 12 1635 1642 2-s2.0-78649887273 10.1136/gut.2010.215665
29. Ravussin Y., Koren O., Spor A., LeDuc C., Gutman R., Stombaugh J., Knight R., Ley R. E., Leibel R. L., Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity. In press 10.1038/oby.2011.111
30. Zhang C., Zhang M., Wang S., Han R., Cao Y., Hua W., Mao Y., Zhang X., Pang X., Wei C., Zhao G., Chen Y., Zhao L., Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. The ISME Journal 2010 4 2 232 241 2-s2.0-76349111356 10.1038/ismej.2009.112
31. Hildebrandt M. A., Hoffmann C., Sherrill-Mix S. A., Keilbaugh S. A., Hamady M., Chen Y. Y., Knight R., Ahima R. S., Bushman F., Wu G. D., High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009 137 5 1716 1716 2-s2.0-70350110294 10.1053/j.gastro.2009.08.042
32. de la Serre C. B., Ellis C. L., Lee J., Hartman A. L., Rutledge J. C., Raybould H. E., Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology 2010 299 2 G440 G448 2-s2.0-77955595990 10.1152/ajpgi.00098.2010
33. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delmée E., Cousin B., Sulpice T., Chamontin B., Ferrières J., Tanti J. F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 56 7 1761 1772 2-s2.0-34347399563 10.2337/db06-1491 (Pubitemid 47025442)
34. Bäckhed F., Manchester J. K., Semenkovich C. F., Gordon J. I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 979 984 2-s2.0-33846542071 10.1073/pnas.0605374104 (Pubitemid 46154722)
35. Bäckhed F., Ding H., Wang T., Hooper L. V., Gou Y. K., Nagy A., Semenkovich C. F., Gordon J. I., The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004 101 44 15718 15723 2-s2.0-8144226856 10.1073/pnas.0407076101 (Pubitemid 39473554)
36. Rabot S., Membrez M., Bruneau A., Gérard P., Harach T., Moser M., Raymond F., Mansourian R., Chou C. J., Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. The FASEB Journal 2010 24 12 4948 4959 2-s2.0-78649741587 10.1096/fj.10-164921
37. Mandard S., Zandbergen F., Nguan S. T., Escher P., Patsouris D., Koenig W., Kleemann R., Bakker A., Veenman F., Wahli W., Müller M., Kersten S., The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. The Journal of Biological Chemistry 2004 279 33 34411 34420 2-s2.0-4544274752 10.1074/jbc.M403058200 (Pubitemid 39318067)
38. Kersten S., Mandard S., Tan N. S., Escher P., Metzger D., Chambon P., Gonzalez F. J., Desvergne B., Wahli W., Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. The Journal of Biological Chemistry 2000 275 37 28488 28493 2-s2.0-0034666157
39. Bäckhed F., Manchester J. K., Semenkovich C. F., Gordon J. I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 979 984 2-s2.0-33846542071 10.1073/pnas.0605374104 (Pubitemid 46154722)
40. Fleissner C. K., Huebel N., Abd El-Bary M. M., Loh G., Klaus S., Blaut M., Absence of intestinal microbiota does not protect mice from diet-induced obesity. The British Journal of Nutrition 2010 104 6 919 929 2-s2.0-77957262599 10.1017/S0007114510001303
41. Xu J., Gordon J. I., Honor thy symbionts. Proceedings of the National Academy of Sciences of the United States of America 2003 100 18 10452 10459 2-s2.0-0142026205 10.1073/pnas.1734063100 (Pubitemid 37071899)
42. Wostmann B. S., Gernfree and Gnotobiotic Animal Models, Background and Applications 1996 CRC
43. Wostmann B. S., Gernfree and Gnotobiotic Animal Models, Background and Applications 1996 CRC
44. Larsen N., Vogensen F. K., van den Berg F. W. J., Nielsen D. S., Andreasen A. S., Pedersen B. K., Al-Soud W. A., Sorensen S. J., Hansen L. H., Jakobsen M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010 5 2 2-s2.0-77949393654 10.1371/journal.pone. 0009085 e9085
45. Wu X., Ma C., Han L., Nawaz M., Gao F., Zhang X., Yu P., Zhao C., Li L., Zhou A., Wang J., Moore J. E., Cherie Millar B., Xu J., Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 2010 61 1 69 78 2-s2.0-77953650911 10.1007/s00284-010-9582- 9
46. Koren O., Spor A., Felin J., Fåk F., Stombaugh J., Tremaroli V., Behre C. J., Knight R., Fagerberg B., Ley R. E., rel222@cornell.edu Bäckhed F., fredrik.backhed@wlab.gu.se Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 2011 108 supplement 1 4592 4598 10.1073/pnas.1011383107
47. Wen L., Ley R. E., Volchkov P. Y., Stranges P. B., Avanesyan L., Stonebraker A. C., Hu C., Wong F. S., Szot G. L., Bluestone J. A., Gordon J. I., Chervonsky A. V., Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008 455 7216 1109 1113 2-s2.0-54549122338 10.1038/nature07336
48. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes. The Journal of Clinical Investigation 2005 115 5 1111 1119 2-s2.0-18244370762 10.1172/JCI200525102 (Pubitemid 40629025)
49. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P. D., Burcelin R. G., Corthesy I., Macé K., Chou C. J., Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. The FASEB Journal 2008 22 7 2416 2426 2-s2.0-46749098265 10.1096/fj.07-102723 (Pubitemid 351948659)
50. Barton G. M., Kagan J. C., A cell biological view of toll-like receptor function: regulation through compartmentalization. Nature Reviews Immunology 2009 9 8 535 541 2-s2.0-68849085894 10.1038/nri2587
51. Ting J. P. Y., Lovering R. C., Alnemri E. S., Bertin J., Boss J. M., Davis B. K., Flavell R. A., Girardin S. E., Godzik A., Harton J. A., Hoffman H. M., Hugot J. P., Inohara N., MacKenzie A., Maltais L. J., Nunez G., Ogura Y., Otten L. A., Philpott D., Reed J. C., Reith W., Schreiber S., Steimle V., Ward P. A., The NLR gene family: a standard nomenclature. Immunity 2008 28 3 285 287 2-s2.0-40449140937 10.1016/j.immuni.2008.02.005 (Pubitemid 351350631)
52. Clarke T. B., Weiser J. N., weiser@mail.med.upenn.edu Intracellular sensors of extracellular bacteria. Immunological Reviews 2011 243 1 9 25 10.1111/j.1600-065X.2011.01039.x
53. Poltorak A., He X., Smirnova I., Liu M. Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998 282 5396 2085 2088 2-s2.0-0032509295 10.1126/science.282.5396.2085 (Pubitemid 29001265)
54. Lee J. Y., Hwang D. H., The modulation of inflammatory gene expression by lipids: mediation through toll-like receptors. Molecules and Cells 2006 21 2 174 185 2-s2.0-33646543284
55. Feingold K. R., Staprans I., Memon R. A., Moser A. H., Shigenaga J. K., Doerrler W., Dinarello C. A., Grunfeld C., Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. Journal of Lipid Research 1992 33 12 1765 1776 2-s2.0-0027098040 (Pubitemid 23006653)
56. Maitra U., Gan L., Chang S., Li L., lwli@vt.edu Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating ccaat/enhancer-binding protein δ Journal of Immunology 2011 186 7 4467 4473 10.4049/jimmunol.1003300
57. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of Clinical Investigation 2006 116 11 3015 3025 2-s2.0-33750584214 10.1172/JCI28898 (Pubitemid 44684486)
58. Poggi M., Bastelica D., Gual P., Iglesias M. A., Gremeaux T., Knauf C., Peiretti F., Verdier M., Juhan-Vague I., Tanti J. F., Burcelin R., Alessi M. C., C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007 50 6 1267 1276 2-s2.0-34247884376 10.1007/s00125-007-0654-8 (Pubitemid 46701560)
59. Davis J. E., Gabler N. K., Walker-Daniels J., Spurlock M. E., Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 2008 16 6 1248 1255 2-s2.0-44449110675 10.1038/oby.2008.210 (Pubitemid 351770507)
60. Erridge C., Attina T., Spickett C. M., Webb D. J., A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. American Journal of Clinical Nutrition 2007 86 5 1286 1292 2-s2.0-36249005027 (Pubitemid 350126229)
61. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., Burcelin R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008 57 6 1470 1481 2-s2.0-48249125862 10.2337/db07-1403
62. Cani P. D., Knauf C., Iglesias M. A., Drucker D. J., Delzenne N. M., Burcelin R., Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006 55 5 1484 1490 2-s2.0-33745126131 10.2337/db05-1360 (Pubitemid 44195391)
63. Cani P. D., Neyrinck A. M., Fava F., Knauf C., Burcelin R. G., Tuohy K. M., Gibson G. R., Delzenne N. M., Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007 50 11 2374 2383 2-s2.0-34848912627 10.1007/s00125-007-0791-0 (Pubitemid 47512397)
64. Creely S. J., McTernan P. G., Kusminski C. M., Fisher F. M., Da Silva N. F., Khanolkar M., Evans M., Harte A. L., Kumar S., Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American Journal of Physiology 2007 292 3 E740 E747 2-s2.0-33947182436 10.1152/ajpendo.00302.2006 (Pubitemid 46411051)
65. Pussinen P. J., pirkko.pussinen@helsinki.fi Havulinna A. S., Lehto M., Sundvall J., Salomaa V., Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011 34 2 392 397 10.2337/dc10-1676
66. Lassenius M. I., Pietilainen K. H., Kaartinen K., Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011 34 8 1809 1815
67. Wiedermann C. J., Kiechl S., Dunzendorfer S., Schratzberger P., Egger G., Oberhollenzer F., Willeit J., Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. Journal of the American College of Cardiology 1999 34 7 1975 1981 2-s2.0-0033405387 10.1016/S0735-1097(99)00448-9 (Pubitemid 30002653)
68. Peschel T., Schönauer M., Thiele H., Anker S., Schuler G., Niebauer J., Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. European Journal of Heart Failure 2003 5 5 609 614 2-s2.0-0347991617 10.1016/S1388-9842(03)00104-1 (Pubitemid 38043965)
69. Yarur A. J., Deshpande A. R., Pechman D. M., Tamariz L., Abreu M. T., Sussman D. A., dsussman@med.miami.edu Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. American Journal of Gastroenterology 2011 106 4 741 747 10.1038/ajg.2011.63
70. Cani P. D., Possemiers S., Van De Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D. M., Muccioli G. G., Delzenne N. M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009 58 8 1091 1103 2-s2.0-65249099918 10.1136/gut.2008.165886
71. Muccioli G. G., Naslain D., Bäckhed F., Reigstad C. S., Lambert D. M., Delzenne N. M., Cani P. D., The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 2010 6, article 392 2-s2.0-77955153069 10.1038/msb.2010.46
72. Neal M. D., Leaphart C., Levy R., Prince J., Billiar T. R., Watkins S., Li J., Cetin S., Ford H., Schreiber A., Hackam D. J., Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. Journal of Immunology 2006 176 5 3070 3079 2-s2.0-33644522719
73. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E., Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 2009 50 1 90 97 2-s2.0-63449098729 10.1194/jlr.M800156-JLR200
74. Ghanim H., Abuaysheh S., Sia C. L., Korzeniewski K., Chaudhuri A., Fernandez-Real J. M., Dandona P., Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009 32 12 2281 2287 2-s2.0-72249106180 10.2337/dc09-0979
75. Laugerette F., Vors C., Géloën A., Chauvin M. A., Soulage C., Lambert-Porcheron S., Peretti N., Alligier M., Burcelin R., Laville M., Vidal H., Michalski M. C., Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. Journal of Nutritional Biochemistry 2011 22 1 53 59 2-s2.0-78649978620 10.1016/j.jnutbio.2009.11.011
76. Muzio M., Bosisio D., Polentarutti N., D'amico G., Stoppacciaro A., Mancinelli R., Van't Veer C., Penton-Rol G., Ruco L. P., Allavena P., Mantovani A., Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. Journal of Immunology 2000 164 11 5998 6004 2-s2.0-0034123135 (Pubitemid 30389848)
77. Hayashi F., Smith K. D., Ozinsky A., Hawn T. R., Yi E. C., Goodlett D. R., Eng J. K., Akira S., Underhill D. M., Aderem A., The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001 410 6832 1099 1103 2-s2.0-0035953543 10.1038/35074106 (Pubitemid 32391041)
78. Vijay-Kumar M., Aitken J. D., Carvalho F. A., Cullender T. C., Mwangi S., Srinivasan S., Sitaraman S. V., Knight R., Ley R. E., Gewirtz A. T., Metabolie syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010 328 5975 228 231 2-s2.0-77950250064 10.1126/science.1179721
79. Mogensen T. H., Pathogen recognition and inflammatory signaling in innate immune defenses. Clinical Microbiology Reviews 2009 22 2 240 273 2-s2.0-66449088641 10.1128/CMR.00046-08
80. Akira S., Mammalian Toll-like receptors. Current Opinion in Immunology 2003 15 1 5 11 2-s2.0-0037290876 10.1016/S0952-7915(02)00013-4 (Pubitemid 35454185)
81. Himes R. W., Smith C. W., Tlr2 is critical for diet-induced metabolic syndrome in a murine model. The FASEB Journal 2010 24 3 731 739 2-s2.0-77952315676 10.1096/fj.09-141929
82. Kuo L. H., Tsai P. J., Jiang M. J., Chuang Y. L., Yu L., Lai K. T. A., Tsai Y. S., Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia 2010 54 1 168 179 2-s2.0-77957999826 10.1007/s00125-010-1931-5
83. Caricilli A. M., Nascimento P. H., Pauli J. R., Tsukumo D. M. L., Velloso L. A., Carvalheira J. B., Saad M. J. A., Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. Journal of Endocrinology 2008 199 3 399 406 2-s2.0-57449083385 10.1677/JOE-08-0354
84. Clarke T. B., Davis K. M., Lysenko E. S., Zhou A. Y., Yu Y., Weiser J. N., Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Medicine 2010 16 2 228 231 2-s2.0-76249120134 10.1038/nm.2087
85. Girardin S. E., Boneca I. G., Carneiro L. A. M., Antignac A., Jéhanno M., Viala J., Tedin K., Taha M. K., Labigne A., Zähringer U., Coyle A. J., DiStefano P. S., Bertin J., Sansonetti P. J., Philpott D. J., Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003 300 5625 1584 1587 2-s2.0-0038615855 10.1126/science.1084677 (Pubitemid 36682892)
86. Girardin S. E., Travassos L. H., Hervé M., Blanot D., Boneca I. G., Philpott D. J., Sansonetti P. J., Mengin-Lecreulx D., Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. The Journal of Biological Chemistry 2003 278 43 41702 41708 2-s2.0-0142180157 10.1074/jbc.M307198200 (Pubitemid 37310428)
87. Girardin S. E., Boneca I. G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D. J., Sansonetti P. J., Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. The Journal of Biological Chemistry 2003 278 11 8869 8872 2-s2.0-0012722659 10.1074/jbc.C200651200 (Pubitemid 36800360)
88. Stroh T., Batra A., Glauben R., Fedke I., Erben U., Kroesen A., Heimesaat M. M., Bereswill S., Girardin S., Zeitz M., Siegmund B., Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes. Journal of Immunology 2008 181 5 3620 3627 2-s2.0-51549091042
89. Zhao L., ling.zhao@utk.edu Hu P., Zhou Y., Purohit J., Hwang D., NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes. American Journal of Physiology 2011 301 4 E587 E598 10.1152/ajpendo.00709.2010
90. Schertzer J. D., Tamrakar A. K., Magalhães J. G., Pereira S., Bilan P. J., Fullerton M. D., Liu Z., Steinberg G. R., Giacca A., Philpott D. J., Klip A., amira@sickkids.ca NOD1 activators link innate immunity to insulin resistance. Diabetes 2011 60 9 2206 2215 10.2337/db11-0004
91. Tamrakar A. K., Schertzer J. D., Chiu T. T., Foley K. P., Bilan P. J., Philpott D. J., Klip A., NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance. Endocrinology 2010 151 12 5624 5637 2-s2.0-78649817454 10.1210/en.2010-0437
92. Martin F. P. J., Sprenger N., Montoliu I., Rezzi S., Kochhar S., Nicholson J. K., Dietary modulation of gut functional ecology studied by fecal metabonomics. Journal of Proteome Research 2010 9 10 5284 5295 2-s2.0-77957368030 10.1021/pr100554m
93. Swann J. R., j.r.swann@reading.ac.uk Tuohy K. M., Lindfors P., Brown D. T., Gibson G. R., Wilson I. D., Sidaway J., Nicholson J. K., Holmes E., elaine.holmes@imperial.ac.uk Variation in antibiotic-induced microbial recolonization impacts on the host metabolic phenotypes of rats. Journal of Proteome Research 2011 10 8 3590 3603 10.1021/pr200243t
94. Wolever T. M. S., Fernandes J., Rao A. V., Serum acetate:propionate ratio is related to serum cholesterol in men but not women. Journal of Nutrition 1996 126 11 2790 2797 2-s2.0-0029961281 (Pubitemid 26376616)
95. Jenkins D. J. A., Wolever T. M. S., Jenkins A., Brighenti F., Vuksan V., Rao A. V., Cunnane S. C., Ocana A., Corey P., Vezina C., Connelly P., Buckley G., Patten R., Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. American Journal of Clinical Nutrition 1991 54 1 141 147 2-s2.0-0025916728 (Pubitemid 21898929)
96. Wolever T. M. S., Spadafora P., Eshuis H., Interaction between colonic acetate and propionate in humans. American Journal of Clinical Nutrition 1991 53 3 681 687 2-s2.0-0025736905 (Pubitemid 21917642)
97. Hosseini E., Grootaert C., Verstraete W., Van de Wiele T., tom.vandewiele@ugent.be Propionate as a health-promoting microbial metabolite in the human gut. Nutrition Reviews 2011 69 5 245 258 10.1111/j.1753-4887.2011. 00388.x
98. Brown A. J., Goldsworthy S. M., Barnes A. A., Eilert M. M., Tcheang L., Daniels D., Muir A. I., Wigglesworth M. J., Kinghorn I., Fraser N. J., Pike N. B., Strum J. C., Steplewski K. M., Murdock P. R., Holder J. C., Marshall F. H., Szekeres P. G., Wilson S., Ignar D. M., Foord S. M., Wise A., Dowell S. J., The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry 2003 278 13 11312 11319 2-s2.0-0038363378 10.1074/jbc.M211609200 (Pubitemid 36792688)
99. Le Poul E., Loison C., Struyf S., Springael J. Y., Lannoy V., Decobecq M. E., Brezillon S., Dupriez V., Vassart G., Van Damme J., Parmentier M., Detheux M., Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. The Journal of Biological Chemistry 2003 278 28 25481 25489 2-s2.0-0038491435 10.1074/jbc.M301403200 (Pubitemid 36835299)
100. Nilsson N. E., Kotarsky K., Owman C., Olde B., Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochemical and Biophysical Research Communications 2003 303 4 1047 1052 2-s2.0-0037453280 10.1016/S0006-291X(03)00488-1 (Pubitemid 36390250)
101. Hong Y. H., Nishimura Y., Hishikawa D., Tsuzuki H., Miyahara H., Gotoh C., Choi K. C., Feng D. D., Chen C., Lee H. G., Katoh K., Roh S. G., Sasaki S., Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 2005 146 12 5092 5099 2-s2.0-27844440904 10.1210/en.2005-0545 (Pubitemid 41653022)
102. Karaki S. I., Mitsui R., Hayashi H., Kato I., Sugiya H., Iwanaga T., Furness J. B., Kuwahara A., Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell and Tissue Research 2006 324 3 353 360 2-s2.0-33646376658 10.1007/s00441-005-0140-x (Pubitemid 43673476)
103. Ge H., Li X., Weiszmann J., Wang P., Baribault H., Chen J. L., Tian H., Li Y., Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008 149 9 4519 4526 2-s2.0-50449087891 10.1210/en.2008-0059
104. Xiong Y., Miyamoto N., Shibata K., Valasek M. A., Motoike T., Kedzierski R. M., Yanagisawa M., Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proceedings of the National Academy of Sciences of the United States of America 2004 101 4 1045 1050 2-s2.0-0742305675 10.1073/pnas.2637002100 (Pubitemid 38160581)
105. Bjursell M., Admyre T., Göransson M., Marley A. E., Smith D. M., Oscarsson J., Bohlooly-Y M., Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. American Journal of Physiology 2011 300 1 E211 E220 2-s2.0-78650800467 10.1152/ajpendo.00229.2010
106. Wang Z., Klipfell E., Bennett B. J., Koeth R., Levison B. S., Dugar B., Feldstein A. E., Britt E. B., Fu X., Chung Y. -M., Wu Y., Schauer P., Smith J. D., Allayee H., Tang W. H.W., Didonato J. A., Lusis A. J., Hazen S. L., hazens@ccf.org Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011 472 7341 57 63 10.1038/nature09922
107. Dumas M. E., Barton R. H., Toye A., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V., Lindon J. C., Mitchell S. C., Holmes E., McCarthy M. I., Scott J., Gauguier D., Nicholson J. K., Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proceedings of the National Academy of Sciences of the United States of America 2006 103 33 12511 12516 2-s2.0-33747618036 10.1073/pnas.0601056103 (Pubitemid 44267289)
108. Stella C., Beckwith-Hall B., Cloarec O., Holmes E., Lindon J. C., Powell J., Van Der Ouderaa F., Bingham S., Cross A. J., Nicholson J. K., Susceptibility of human metabolic phenotypes to dietary modulation. Journal of Proteome Research 2006 5 10 2780 2788 2-s2.0-33750213694 10.1021/pr060265y (Pubitemid 44604232)
109. Nicholson J. K., Holmes E., Wilson I. D., Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology 2005 3 5 431 438 2-s2.0-17844404232 10.1038/nrmicro1152 (Pubitemid 40590386)
110. Waldram A., Holmes E., Wang Y., Rantalainen M., Wilson I. D., Tuohy K. M., McCartney A. L., Gibson G. R., Nicholson J. K., Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. Journal of Proteome Research 2009 8 5 2361 2375 2-s2.0-66749118301 10.1021/pr8009885
111. Calvani R., Miccheli A., Capuani G., Tomassini Miccheli A., Puccetti C., Delfini M., Iaconelli A., Nanni G., Mingrone G., Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. International Journal of Obesity 2010 34 6 1095 1098 2-s2.0-77953611756 10.1038/ijo.2010.44
112. Holmes E., Loo R. L., Stamler J., Bictash M., Yap I. K. S., Chan Q., Ebbels T., De Iorio M., Brown I. J., Veselkov K. A., Daviglus M. L., Kesteloot H., Ueshima H., Zhao L., Nicholson J. K., Elliott P., Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008 453 7193 396 400 2-s2.0-43749087841 10.1038/nature06882 (Pubitemid 351693125)
113. Verberkmoes N. C., Russell A. L., Shah M., Godzik A., Rosenquist M., Halfvarson J., Lefsrud M. G., Apajalahti J., Tysk C., Hettich R. L., Jansson J.